Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04604457 · ClinicalTrials.gov registry record · NA
Impact of Predictive Modeling on Time to Palliative Care in an Outpatient Primary Care Population
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 127,070
- Enrollment target
NCT04604457: Completed NA study, sponsored by Mayo Clinic.
NCT04604457 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 127,070 participants, above the 1,401-participant average among 58,714 other NA trials with a reported enrollment target (8970% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04604457, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 127,070 participants
- Enrollment target
Study Summary
A machine learning algorithm will be used to accurately identify patients in certain primary care units who may benefit from palliative care consults.
Primary Outcome
Time to electronic record of consult by the palliative care team in the outpatient setting
Interventions
- OTHER Palliative care contacts primary care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 127,070 participants |
| Start Date | 2020-08-31 |
| Est. Completion | 2021-05-31 |
| Phase | NA |
What the finished NCT04604457 record still lists
NCT04604457 is an interventional study that assigns participants to a tested intervention. Its 127,070 participants enrollment target places it among the larger protocols in the corpus, above the 1,401-participant average among 58,714 other NA trials with a reported enrollment target (8970% higher).
The record links to 0 conditions, and to 1 intervention - of which Palliative care contacts primary care is the first listed.
NCT04604457 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04604457 about?
NCT04604457 is a clinical study titled "Impact of Predictive Modeling on Time to Palliative Care in an Outpatient Primary Care Population". A machine learning algorithm will be used to accurately identify patients in certain primary care units who may benefit from palliative care consults.
What is the current status of trial NCT04604457?
This trial is currently completed. It is a NA study. The enrollment target is 127,070 participants. The study started on 2020-08-31. Estimated completion is 2021-05-31.
What interventions are being tested in trial NCT04604457?
The interventions under investigation include: Palliative care contacts primary care (OTHER).
Who is sponsoring clinical trial NCT04604457?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04604457's enrollment target sits among peer trials
127,070 2nd of 2000 the highest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02693509 · 128,026 participants
Get With The Guidelines-Heart Failure Registry
- NCT05994482 · 130,000 participants
Surveillance Colonoscopy in Older Adults: The SurvOlderAdults Study
- NCT03897374 · 120,000 participants
Strategic Targeting for Optimal Prevention of Cancer
- NCT06608758 · 120,000 participants
End Diagnostic Overshadowing:Addressing Ableism in Diagnoses
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI